The U.S. Food and Drug Administration has approved the first vaccine that protects against four strains of the common flu.
A number of studies have examined the impact of plasmaderived or recombinant factor VIII (FVIII) replacement therapy on inhibitor antibody development in hemophilia A patients, with conflicting results.
Human albumin is known to exert a neuroprotective effect in animal models of cerebral ischemia and humans with various intracranial pathologies.
Canadian scientists are working on an intravenous treatment for Alzheimer’s that could halt the progression of the disease and improve cognitive functions.
A recent study shows that specific autoantibodies found in a modest proportion of mothers with an autistic child may provide more evidence of an immune component related to autism.
On July 27, 2011, Royce Lamberth, chief judge of the District of Columbia District Court, ruled that the U.S. government can continue funding embryonic stem-cell research.
Scientists in China have successfully grown human serum albumin in rice, which has been successfully used to grow other human proteins.
A research team at the National Institute of Allergy and Infectious Diseases found that people with Job’s syndrome have a lower number of immune memory cells.
The U.S. Department of Health and Human Services has published a new rule for electronic funds transfers in healthcare.
Updates about recent clinical trials, including the evaluation of Pennvax-B for HIV, tofacitinib for rheumatoid arthritis a universal flu vaccine and more.
Global production of seasonal flu vaccine is expected to double to 1.7 billion doses by 2015, with 11 new manufacturers expected in developing countries.
Responding to concerns about the initial Accountable Care Organization rules, the U.S. Department of Health and Human Services has made several concessions.